The Small Animal Imaging (In Vivo) Market Size was valued at USD 1.16 billion in 2023 and is projected to reach USD 2.27 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.76% during the forecast period 2024–2032, according to the latest report by SNS Insider. This growth is being fueled by increasing demand for non-invasive imaging techniques in preclinical research, drug development, and disease monitoring.
Small animal imaging (in vivo) techniques, including PET, SPECT, MRI, CT, optical imaging, and ultrasound, are being increasingly adopted by research institutes, biotechnology firms, and pharmaceutical companies. These tools allow for the visualization and quantification of biological processes at the molecular and cellular levels in living animals, which is essential in preclinical testing of new drugs and therapies.
Key Market Drivers
The increasing prevalence of chronic diseases, growing investments in pharmaceutical R&D, and the need for advanced preclinical imaging technologies are among the key drivers of the small animal imaging market. The shift towards personalized medicine and the growing importance of translational research have further propelled the adoption of these imaging systems. Additionally, technological advancements that improve the sensitivity, resolution, and accuracy of imaging modalities are playing a pivotal role in market expansion.
Moreover, non-invasive imaging techniques significantly reduce the number of animals used in experiments by enabling longitudinal studies on the same animal subject, aligning with global ethical standards and encouraging broader adoption of in vivo imaging systems.
Market Segmentation Insights
The small animal imaging market is segmented by modality, application, and end-user. By modality, optical imaging remains the most widely used due to its affordability and ease of use, followed by MRI and PET imaging. In terms of application, oncology dominates the market, given the high incidence of cancer worldwide and the need for advanced imaging tools to track tumor progression and response to treatment.
Pharmaceutical and biotechnology companies continue to lead the end-user segment, contributing significantly to market growth through increased funding for preclinical studies. Academic and research institutions are also expanding their use of in vivo imaging platforms to support ongoing biomedical research projects.
Regional Analysis
North America remains the leading region in the global small animal imaging market, primarily due to strong R&D investments, favorable government funding, and a robust pharmaceutical industry. The presence of key market players and advanced research infrastructure also contribute to the region’s dominance.
Asia-Pacific is expected to witness the fastest growth over the forecast period. This surge is driven by expanding healthcare infrastructure, rising R&D expenditure, and increasing awareness of advanced imaging technologies in countries such as China, India, and Japan.
Competitive Landscape
The market is highly competitive, with key players focusing on strategic partnerships, product innovation, and mergers and acquisitions to strengthen their market position. Companies are increasingly investing in artificial intelligence (AI) integration and multimodal imaging platforms to provide more comprehensive and accurate preclinical insights.
Some prominent players in the small animal imaging market include:
- PerkinElmer Inc.
- Bruker Corporation
- FUJIFILM VisualSonics Inc.
- Mediso Ltd.
- Aspect Imaging Ltd.
- LI-COR Biosciences
- MILabs B.V.
- TriFoil Imaging
Future Outlook
The small animal imaging (in vivo) market is expected to experience robust growth through 2032, propelled by continued innovation in imaging modalities and the growing need for more precise preclinical data. As the pharmaceutical industry moves toward more targeted and personalized therapies, the role of small animal imaging in translational research will become even more vital.
With an increasing number of research institutions and biotech companies recognizing the value of in vivo imaging, the market is set to witness widespread adoption, especially in emerging economies. The integration of AI, machine learning, and advanced data analytics is also expected to transform the future landscape of small animal imaging, enhancing diagnostic accuracy and reducing research timelines.
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
📧 info@snsinsider.com
📞 +1-415-230-0044 (US) | +91-7798602273 (IND)
Other Trending Reports
Weight Management Services Market Share
Healthcare Waste Management Market Share